CliffBio
small molecule

BETIMOL

TIMOLOL

Loss of exclusivity—loss of exclusivity
CompanyThea →See this company's full patent-cliff portfolio

Drug detail

Brand nameBETIMOL
Active ingredientTIMOLOL
Strength0.5%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMarch 1995
Marketing statusRX

More from Thea

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BETIMOL patent cliff — loss of exclusivity — | CliffBio